跳至主要内容
临床试验/CTRI/2018/11/016467
CTRI/2018/11/016467已完成Unknown

An Observational, Prospective, Post-Marketing Clinical Study of the ACRYSOF® IQ PanOptix Multifocal IOL in an Indian Population

Alcon Laboratories India Pvt Ltd4 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2018年5月12日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
80
试验地点
4
主要终点
Best corrected binocular visual acuity at distance (4 m) post bilateral implantation

研究概览

简要总结

Brief Summary : The purpose of this Post Marketing Study is to study the safety and effectiveness of the ACRYSOF IQ PanOptix intraocular lens (IOL) in an Indian population.

Detailed Description: The study population will consist of adult Indian males and females, at least 18 years of age or older at the time of screening, with no ocular pathology that could confound study outcomes, who are advised bilateral cataract extraction

and who desire an IOL that provides the potential for correction of near, intermediate, and distance vision. Both eyes will be implanted. The second eye surgery will take place 15-30 days after the first eye surgery. Subjects will be followed for approximately 3 months after the second eye surgery. Total individual subject participation will be approximately 4 months. This study will be conducted in India.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • •Able to comprehend and willing to sign informed consent and complete all required postoperative follow-up procedures;
  • •Advised cataract extraction in both eyes and agreed for bilateral implantation of ACRYSOF IQ PanOptix lens;
  • •Preoperative regular keratometric astigmatism of ≤1.0 D in both eyes.
  • •Other protocol-specified inclusion criteria may apply.

排除标准

  • •Pregnant or lactating, current or planned, during the course of the study;
  • •Retinal abnormalities (Macular Degeneration, dystrophy, edema , traction or other pathologies affecting vision);
  • •Clinically significant corneal abnormalities; 4.History of retinal conditions; 5.Previous refractive surgery, including LASIK; 6.Glaucoma; 7.Any condition that may not be appropriate to this study, as per the Investigator’s expert medical opinion.
  • •Other protocol-specified exclusion criteria may apply.

结局指标

主要结局

Best corrected binocular visual acuity at distance (4 m) post bilateral implantation

时间窗: At 3 months

次要结局

  • 1. Subjects will be assessed for monocular visual acuity at 1 month after each(implantation and monocular as well as binocular visual acuity 3 months post bilateral (second eye) implantation via various assessments)

研究者

发起方
Alcon Laboratories India Pvt Ltd
申办方类型
Pharmaceutical industry-Indian

研究点 (4)

Loading locations...

相似试验